Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2011 Jul;4(4):467–476. doi: 10.1161/CIRCOUTCOMES.110.960468

Table 3.

Baseline characteristics of patients eligible for and enrolled in TRIUMPH

Characteristic Not Enrolled
n=1466
Enrolled
n=3537*
p-value Follow-up
n=3632
No Follow-up
n=631
p-value
Age (years) 62.2±14.5 58.6±12.4 <0.001 59.3±12.0 57.1±13.7 <0.001
Male 65.7% 66.9% 0.40 66.9% 65.6% 0.54
White 77.1% 64.4% <0.001 72.5% 55.7% <0.001
No insurance 24.5% 23.4% 0.42 21.4% 28.9% <0.001
Diabetes mellitus 31.0% 31.7% 0.63 29.7% 35.0% 0.007
Hypertension 65.9% 69.3% 0.104
Prior myocardial infarction 20.2% 24.6% 0.012
Prior heart failure 7.4% 14.3% <0.001
ST-elevations on admission 45.5% 40.3% 0.019
Peak troponin (ng/mL) 29.3±75.2 23.7±55.3 0.075
Ejection fraction (%) 49.0±12.9 47.2±13.8 0.004
Coronary angiography 93.5% 86.2% <0.001
GRACE score (6-month mortality)60 100.1±29.2 100.8±34.3 0.554
Length of stay (days) 5.5±6.5 6.5±8.5 <0.001
*

From the top 10 enrolling hospitals; represents 81% of the total study population

Includes only patients who survived to 1-month (i.e. had the opportunity to participate in follow-up)